About 200 reports

Global Sepsis Diagnostics Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Product Analysis ##. ## Technology Analysis ##. ## Application Analysis ##. ## End User Anal

  • Blood Disease
  • Diagnostics
  • United States
  • Forecast
  • Market Size

The company operates in one business segment.

  • Blood Disease
  • Europe
  • World
  • Illumina, Inc.
  • Roche Group
  • 2.2.5 Laboratory Tests for Pulmonary Embolism

It can also show other pathologies and lung defects.

  • Blood Disease
  • Cardiovascular Disease
  • World
  • Cyclopharm Limited
  • Lifesciences Limited

Laboratories performing genetic tests can be accredited through the Clinical Pathology Accreditation UK Ltd scheme.

  • Blood Disease
  • North America
  • United States
  • World
  • Forecast

Oral Mucositis: understanding the pathology and management.

  • Blood Disease
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • 7.2.2 Pipeline Programs Targeting Hepcidin

Indeed, previous pathology studies have revealed that iron disorders are due to the dysregulation of the hepcidin-ferroportin axis.

  • Blood Disease
  • World
  • Acceleron Pharma, Inc.
  • La Jolla Pharmaceutical Company
  • Omeros Corporation

EACH PARTY, THROUGH ITS REPRESENTATIVES, SHALL HAVE ONE (##) VOTE ON THE JSC AND EACH SUBCOMMITTEE.

  • Blood Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC

As of a 2017 report published in the Journal of Genetic Counselling, the counts are very low, including ##: ##, ##, ## in Indonesia, ##: ##, ##, ## in Hong Kong, ##: ##, ##, ## in Singapore, ##:##, ## in Taiwan, ##: ##, ##, ## in Vietnam, ##: ##, ##,

  • Blood Disease
  • 23andMe, Inc.
  • Cepheid
  • Illumina, Inc.
  • Sequenom, Inc.
  • 9 Appendix

Molecular Pathology; ##(##): ##-## Brand B, et al. (2015).

  • Blood Disease
  • World
  • CSL Behring GmbH
  • Novo Nordisk Group
  • Pfizer Inc.

Pediatric Medicine, Hematology/ Oncology, Medical Oncology, Internal Medicine, Emergency Medicine, and Pathology) and how does this compare to its peers and the overall set of rep-accessible physicians?

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Oncology
  • Pathology
  • United States
  • FEB 14, 2018: FEINSTEIN INSTITUTE RESEARCHER RECEIVES $3.6M IN GRANTS TO STUDY RARE BLEEDING CONDITION

The DOD has placed a research focus on vascular pathologies, like HHT, that might affect military personnel.

  • Blood Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Social Conditions

The clinical course of these pathologies and treatment outcomes vary between the affected individuals.

  • Blood Disease
  • Pathology

Anti-PD-## and anti-PDL-## antibodies are novel drugs used in certain cancers to overcome the immunosuppressive effects of PD-##/ PDL-## signaling in anti-tumor T cells.

  • Blood Disease
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Novartis AG
  • Promedior, Inc.

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • Biogen Idec Inc.
  • CSL Behring GmbH
  • 9.2.5 BMS-936559
  • 4.1.1 ETIOLOGY

DIAGNOSTIC PATHOLOGY; ##(##): ##.

  • Blood Disease
  • Demand
  • Faron Pharmaceuticals Ltd
  • Ferring International Center S.A.
  • Shionogi & Co., Ltd.

Blood; ##(##): ##-##.

  • Blood Disease
  • Baxalta Incorporated
  • Biogen Idec Inc.
  • CSL Behring GmbH
  • Novo Nordisk Group

Heather holds a Bachelor' s degree in Molecular and Cell Biology from the University of Connecticut, and a PhD in Pathology and Cell and Molecular Biology from Boston University School of Medicine.

  • Blood Disease
  • United States
  • Amgen Inc.
  • BeyondSpring Pharmaceuticals Inc.
  • Helsinn Group

DISEASES OF AQUATIC ORGANISMS ##, ##, ##-##.

  • Aquaculture
  • Blood Disease
  • World
  • Supply
  • Zoetis Inc.
  • 9 Appendix

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Novo Nordisk Group

American Journal of Clinical Pathology; ##(##): ##-##.

  • Blood Disease
  • Japan
  • United States
  • Eisai Co., Ltd.
  • Rigel Pharmaceuticals, Inc.
  • REFERENCES

Modern Pathology. 2012; ##():##- ## ##.

  • Blood Disease
  • SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES,
  • KEY FINDINGS

The sepsis diagnostics market projected to grow at a CAGR of 9.1%. The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections,...

  • Blood Disease
  • North America
  • United States
  • Market Size
  • Roche Group

Hemophilia

4546 5000 3864
  • STRENGTHS AND LIMITATIONS

Hemophilia Disease Coverage | Treatment: Hemophilia DMKC## Advate ## ## ## ## ## ## ## ## Kogenate/ Helixate ## ## ## ## ## ## ## ## Xyntha/ ReFacto ## ## ## ## ## ## ## ## Recombinate ## ## ## ## ## ## ## ## Humate P ## ## ## ## ## ## ## ## Beriate P/ N ## ## ## ## ##

  • Blood Disease
  • European Union
  • Japan
  • North America
  • United States

Alsobrook II, DABCC, FACB, Laboratory Site Director and Vice President of Operations for Clinical Genomics Pathology.

  • Blood Disease
  • Diagnostics
  • United States
  • Company
  • Quest Diagnostics Incorporated

BLOOD; ##(##): ##-##.

  • Blood Disease
  • World
  • Demand
  • Baxalta Incorporated
  • Novo Nordisk Group
  • 9 Appendix

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Novo Nordisk Group
  • 9 Appendix

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Novo Nordisk Group

George Abe, as Senior Vice President of Pathology.

  • Blood Disease
  • Medical Device
  • United States
  • Company
  • Deals & Alliance
  • LYMPHATIC FILARIASIS (MULTIVALENT) VACCINE - DRUG PROFILE

The molecules developed by Companies in Phase II and Preclinical stages are ## and ## respectively.

  • Blood Disease
  • United States
  • World
  • Product Initiative
  • AbbVie Inc.
  • LUSPATERCEPT - DRUG PROFILE

ACE-## is currently being evaluated in two Phase ## trials: one in FSHD and one in Charcot-Marie-Tooth (CMT) disease.

  • Blood Disease
  • United States
  • World
  • Product Initiative
  • Acceleron Pharma, Inc.